6-Bromo-8-phenylimidazo[1,2-a]pyrazine
97%
- Product Code: 151482
CAS:
1159815-57-2
Molecular Weight: | 274.12 g./mol | Molecular Formula: | C₁₂H₈BrN₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD12033252 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, Inert Gas |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective binding to enzyme targets, making it valuable in medicinal chemistry research. Also employed in the creation of fluorescent probes for biochemical assays due to its favorable photophysical properties. Commonly utilized in structure-activity relationship (SAR) studies to optimize drug candidates targeting neurological and inflammatory disorders.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | ฿12,950.00 |
+
-
|
250mg | 10-20 days | ฿19,310.00 |
+
-
|
1g | 10-20 days | ฿66,950.00 |
+
-
|
6-Bromo-8-phenylimidazo[1,2-a]pyrazine
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective binding to enzyme targets, making it valuable in medicinal chemistry research. Also employed in the creation of fluorescent probes for biochemical assays due to its favorable photophysical properties. Commonly utilized in structure-activity relationship (SAR) studies to optimize drug candidates targeting neurological and inflammatory disorders.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :